Five University of Missouri faculty members received pilot funding from the Institute of Clinical and Translational Sciences at Washington University in St. Louis. The recipients of these pilot awards received approximately $50,000 per team to advance their research. The following projects received funding:
- “Therapeutic Potential of Myostatin (GDF8) and Activin A Inhibition on Murine Osteogenesis Imperfecta,” by principal investigator Charlotte Phillips, PhD, associate professor of biochemistry.
- “Acute and Chronic Pain Management Using a Mobile Pain Monitoring System,” by principal investigator Illhoi Yoo, PhD, associate professor in the Department of Health Management and Informatics.
- “TRAF3IP2 as a Novel Target to Restore Endothelial Insulin Sensitivity and Function in Type 2 Diabetes,” by principal investigator Jaume Padilla, PhD, assistant professor in the Department of Nutrition and Exercise Physiology.
- “Developing an Intervention to Mitigate Obesity Risk in a Child’s First 1,000 Days,” by principal investigator Julie Kapp, PhD, associate professor in the Department of Health Management and Informatics.
- “Identifying Factors that Impact Implementation of Tobacco Use Treatment in Health Care Settings,” by principal investigator Kevin Everett, PhD, associate professor in the Department of Family and Community Medicine.
Article Spotlight
Read more stories from MU Medicine Magazine Summer 2019